Sentry Investments launches new Portfolio as part of Sentry Personal Pension Portfolios

TORONTO, ON—(Marketwired – June 27, 2017) – Sentry Investments (“Sentry”) is pleased to announce the launch of Sentry Defensive Income Portfolio (the “Portfolio”), a new addition to the Sentry Personal Pension Portfolios line–up.

Sentry Personal Pension Portfolios are a series of five global portfolios built with the long term in mind. Taking a cue from some of the world's most sophisticated investors — pension managers — the portfolios offer dedicated exposure to real assets, including real estate, infrastructure, precious metals and energy, as well as global high–yield bonds. Real assets offer distinct and complementary benefits to traditional equities and bonds, which are also included within each portfolio.

Each of the five portfolios offers a different balance of growth and income depending on an investor's specific needs and goals. The new Portfolio is focused on providing investors with income while also preserving capital.

“Sentry Defensive Income Portfolio provides investors with our most conservative option in the well–rounded Sentry Personal Pension Portfolios roster,” said Philip Yuzpe, President and Chief Executive Officer. “While the Portfolio is low–risk, it offers investors all the benefits of our investment team's expertise and active management, while providing exposure to the asset classes that are favoured by pension managers.”

Sentry Personal Pension Portfolios are managed by a team of nine seasoned Sentry investment managers, with tactical asset allocation provided by Sentry's Asset Allocation Committee: Gaelen Morphet, Executive Vice–President and Chief Investment Officer; James Dutkiewicz, Chief Investment Strategist and Senior Portfolio Manager; and Andy Nasr, Vice–President, Capital Markets and Investment Strategist.

The five portfolios are:

  • Sentry Defensive Income Portfolio
  • Sentry Conservative Income Portfolio
  • Sentry Balanced Income Portfolio
  • Sentry Growth and Income Portfolio
  • Sentry Growth Portfolio

SENTRY INVESTMENTS INC.

Sentry Investments is one of Canada's leading independent investment managers, with more than $18 billion in assets under management. Since opening our doors in 1997, we have earned and kept the trust of more than half a million Canadian investors. Sentry offers a diverse range of investment products and solutions through financial advisors and investment dealers, as well as portfolio management services to a variety of institutional clients. Our disciplined investment philosophy focuses on delivering superior risk–adjusted returns to help investors calmly create wealth.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

Certain statements included in this news release constitute forward–looking statements, including, but not limited to, those identified by the expressions “expect,” “intend,” “will” and similar expressions to the extent they relate to Sentry or the Portfolio. The forward–looking statements are not historical facts but reflect Sentry's current expectations regarding future results or events. These forward–looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Although Sentry believes that the assumptions inherent in the forward–looking statements are reasonable, forward–looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements. Sentry undertakes no obligation to update publicly or otherwise revise any forward–looking statement or information whether as a result of new information, future events or other such factors which affect this information, except as required by law. For a complete disclosure record of the Portoflio and the other mutual funds comprising the Sentry Group of Funds, please visit their respective profiles at www.sedar.com.

Sentry Investments Inc.
Commerce Court West
199 Bay Street, Suite 2700
P.O. Box 108
Toronto, ON M5L 1E2

SG Blocks, Inc. Announces Closing of Public Offering

NEW YORK, NY—(Marketwired – Jun 27, 2017) – SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a premier designer, innovator and fabricator of container–based structures, today announced the closing of its previously announced public offering of 1,500,000 shares of its common stock at a public offering price of $5.00 per share. All of the shares of common stock were offered by SG Blocks.

The shares began trading on the NASDAQ Capital Market on June 22, 2017 under the ticker symbol “SGBX.” The aggregate gross proceeds to SG Blocks from the offering, before deducting the underwriting discounts and commissions and offering expenses, were $7.5 million.

Joseph Gunnar & Co., LLC acted as sole book–running manager for the offering.

The Securities and Exchange Commission (the “SEC”) declared effective a registration statement on Form S–1 relating to these securities on June 21, 2017. A final prospectus relating to this offering was filed with the SEC on June 22, 2017. The offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained by contacting Joseph Gunnar & Co., LLC, Prospectus Department, 30 Broad Street, 11th Floor, New York, NY 10004, telephone 212–440–9600, email: prospectus@jgunnar.com. Investors may also obtain these documents at no cost by visiting the SEC's website at http://www.sec.gov. Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the offering.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About SG Blocks, Inc.

SG Blocks, Inc. is a premier innovator in advancing and promoting the use of code–engineered cargo shipping containers for safe and sustainable construction. The firm offers a product that exceeds many standard building code requirements, and also supports developers, architects, builders and owners in achieving greener construction, faster execution, and stronger buildings of higher value. For more information, visit www.sgblocks.com.

Forward–Looking Statements

This press release contains forward–looking statements about the Company's expectations, beliefs and intentions. Forward–looking statements can be identified by the use of forward–looking words such as “believe”, “expect”, “intend”, “plan”, “may”, “should”, “could”, “might”, “seek”, “target”, “will”, “project”, “forecast”, “continue” or “anticipate” or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward–looking statements involve certain risks and uncertainties, including, among others, factors and risks that could cause the Company's results to differ materially from those expected by Company management or otherwise described in or implied by the statements in this press release. Any forward–looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward–looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in SG Blocks' Registration Statement on Form S–1 filed with the SEC, which is available on the SEC's website, www.sec.gov.

Harbert European Growth Capital Portfolio Company, TrustYou, Acquired by Recruit

LONDON, UNITED KINGDOM—(Marketwired – June 27, 2017) – Recruit, a leading Japanese internet and media group, announced the acquisition of the global leader in guest feedback platform, TrustYou, following a sustained period of impressive growth momentum.

The Harbert European Growth Capital (“HEGC”) investment thesis recognized TrustYou's needs of finding a value–added partner with the expertise to provide long term capital that was as innovative as their business.

The investment aligned goals of founders and shareholders to deliver on growth targets with flexible capital, and we are delighted to have been a part of the exciting journey of European entrepreneurs.

“Our collaboration with HEGC was an important strategic step to achieve our goals and enable us to grow organically. The partnership was highly productive, professional, and entrepreneurial throughout,” says CEO and co–founder Benjamin Jost.

HEGC remains an active investor in the technology and life science industries, having recently closed our landmark 50th investment.

We continue to support growth of entrepreneurial businesses across Europe and look forward to continue working with and expanding our partners and community.

For more information regarding Harbert European Growth Capital please visit our website with details on getting in touch with the investment team at HEGC.

About TrustYou
TrustYou, the world's largest guest feedback platform, provides hotels with insights to improve their guest experience and market to future guests. Guest feedback informs 95% of booking decisions, and TrustYou's guest feedback platform incorporates hundreds of millions of hotel reviews, surveys, social comments, and direct messages through SMS, email, Facebook Messenger and more. This information is analyzed along each step of a traveler's journey, including booking and pre–stay queries, real–time guest request, and post–stay feedback, to generate actionable insights for hundreds of thousands of hotels.

TrustYou's platform is made up of various components, including TrustYou Meta–Reviews, verified global review summaries displayed on travel and search sites like Google, KAYAK, and Hotels.com; TrustYou Messaging, real–time guest messaging service; TrustYou Stars, an advanced guest satisfaction survey tool; TrustYou Analytics, the world's leading online reputation management tool and the accompanying app TrustYou Radar. PMS, CRM, IBE and other hotel software providers can make use of TrustYou Connect, a partner program to integrate TrustYou's guest feedback platform with its products to help their hotel clients to positively influence every stage of the guest journey.

Find more information on TrustYou at: http://www.trustyou.com.

About Harbert European Growth Capital
Harbert European Growth Capital is sponsored by Harbert Management Corporation (“HMC”). HEGC provides flexible, long term and permanent debt capital for technology and life sciences businesses across Europe, and has the ability to support businesses with follow–on reserves and global network of commercial and investor relationships.

About Harbert Management Corporation
Harbert Management Corporation, an alternative asset management firm with approximately $4.9 billion in Regulatory Assets Under Management as of May 31, 2017, is a privately–owned firm formed in 1993 to sponsor alternative asset investment funds. HMC serves foundations and endowments, funds of funds, pension funds, financial institutions, insurance companies, family offices and high net worth individuals across multiple asset classes. Investment strategies include European and U.S. real estate, seniors housing, European and U.S. growth capital, mezzanine debt, independent power and public securities. Additional information about HMC can be found at www.harbert.net.

Sitehands Secures $25 Million Growth Equity Commitment from FTV Capital

NEW YORK, NY—(Marketwired – June 27, 2017) – Sitehands, an innovative provider of enterprise IT field services through a unique two–sided market approach, today announced it has secured a $25 million growth equity commitment from FTV Capital, a leading growth equity investor. Sitehands connects customer specific needs with vetted technicians through a two–sided marketplace and then extends that value to the customer by assuming full accountability for end–to–end service outcomes. The management team's significant domain expertise combined with data and analytics captured via the Sitehands technology platform bring measurable improvement to delivery efficiency and the underlying economics for the customers. The funding is the first institutional capital raised and will be used to expand the team, build out product enhancements, and further deepen the Sitehands network. As part of the transaction, FTV Capital managing partner Brad Bernstein and Sandhill East CEO, Andy Brown, will join the company's board of directors.

Sitehands offers multi–location enterprises an enhanced delivery model that standardizes processes and reduces costs unlike traditional solutions that are inefficient and reliant on long–term onerous contracts and fees. The company's on–demand technology platform can easily scale to offer all types of hands–on IT field work at virtually any location, seamlessly connecting customers and technicians via simplified interactions.

“Sitehands changes the paradigm of technical field service work by providing better service, faster start to finish outcomes, and reduced costs. Enterprise customers benefit by being able to take advantage of consumption economics and on–demand models, giving them the flexibility and agility required in today's competitive and dynamic business markets. Providers benefit through greater efficiency and standardized work requests, both of which translate directly to their bottom line,” explains Sitehands CEO J.P. Rosato. “Furthermore, the platform enables provider business partners, who have the right skills and technical expertise, access to greater opportunities to grow their businesses,” concludes Rosato.

“The Sitehands platform addresses a large and highly inefficient market that is ripe for disruption, solving a massive pain point for multi–location companies,” said Brad Bernstein, FTV Capital managing partner and new board member. “The many financial services enterprises in FTV's Global Partner Network® have validated that the current IT services vendor market is highly fragmented and costly. The Sitehands management team's extensive industry experience has enabled them to build a compelling solution that resonates with enterprise and SMB customers.”

In a short timeframe, Sitehands has successfully won contracts from some of the largest and most demanding enterprise companies in the Fortune 100. The company also continues to rapidly add to its large community of service providers and partners globally. Current large enterprise customers who partner with Sitehands realize significant savings in the form of greater FTE resource efficiency and reductions in truck rolls. These initial customer gains are further amplified as the simplicity and results of using the Sitehands solution attracts more and more use cases inside of those enterprises.

About Sitehands

Sitehands delivers IT field services through a unique two–sided platform which provides orchestration and simplification with end–to–end accountability and continuous optimization. The Sitehands service catalogue spans a range of on–demand and planned IT field services including break–fix, site surveys for compliance and asset management, network technology refresh projects, and new site installations and decommissions across a broad geographic footprint in North America and a growing footprint throughout Europe and Asia. For more information, please visit www.sitehands.com.

About FTV Capital

FTV Capital is a growth equity investment firm that has raised over $2.7 billion to invest in high–growth companies offering a range of innovative solutions in three sectors: enterprise technology & services, financial services and payments & transaction processing. FTV's experienced team leverages its domain expertise and proven track record in each of these sectors to help motivated management teams accelerate growth. FTV also provides companies with access to its Global Partner Network, a group of the world's leading enterprises and executives who have helped FTV portfolio companies for nearly two decades. Founded in 1998, FTV Capital has invested in 98 portfolio companies including enterprise technology companies such as Actimize (acquired by NICE), Aveksa (acquired by EMC), Cloudmark, e–Security (acquired by Novell), KVS (acquired by Veritas), ReliaQuest, and Trustwave (acquired by SingTel). FTV has offices in San Francisco and New York. For more information, please visit www.ftvcapital.com.

CV Sciences, Inc. to Exhibit and Present at the American Association of Naturopathic Physicians 2017 National Conference

LAS VEGAS, NV—(Marketwired – June 27, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), today announced that its industry–dominating brand of hemp–derived cannabidiol oil finished products, PlusCBD Oil™, will be exhibiting at the American Association of Naturopathic Physicians (AANP) 2017 National Conference, held on July 12–15, 2017 at The Arizona Biltmore in Phoenix, AZ.

As the professional association that represents licensed naturopathic physicians, the AANP strives to make naturopathic medicine available to every American and to increase recognition of naturopathic physicians as the identified authorities on natural medicine. Over the last three years, the Company's consumer products division has focused on distributing their PlusCBD Oil™ brand to healthcare providers nationwide.

“Naturopathic physicians truly understand the power of botanical nutrition. We are elated to see the tremendous growth of PlusCBD Oil™ amongst licensed practitioners and the AANP's Annual Conference has been integral in supporting the forward–thinking understanding around this promising ingredient. CV Sciences' continued participation has led to an increase in our distribution network and as a result, has impacted our top line growth,” states Stuart Tomc, VP of Human Nutrition at CV Sciences. “We are extremely excited to showcase our array of products and educate clinicians on current practical and nutritional benefits of hemp–derived CBD.”

VISIT BOOTH 210: CV Sciences invites attendees to visit Booth 210 to learn more about their botanical‐based CBD product line. The Company will additionally feature its brand of practitioner–exclusive products available only to healthcare providers nationwide. Also, CV Sciences will be offering exclusive trade show discounts and show specials to practitioners attending the show.

EXHIBITOR–SPONSORED PRESENTATION: Join the CV Sciences team for an interactive presentation, “Hemp–derived CBD: The Missing Ingredient in your Tool Kit,” on Thursday, July 13th, 2017 at 10 am in the AANP Conference Exhibit Hall at the Arizona Biltmore. Presented by Aimée Shunney, ND, Medical Advisor to CV Sciences, the presentation will cover the interactions of CBD and the human endocannabinoid system as it relates to human health, the importance of proper quality control measures to ensure safety and efficacy, and how CV Sciences demonstrates Full Traceability – From Seed to Shelf™.

NATURAL PARTNERS PANEL: CV Sciences is honored to participate in practitioner wholesale distributor Natural Partners' Roundtable Panel entitled, “CBD: State of the Science, Clinical Applications and What We Know,” on Friday, July 14th, 2017 in the Prescott Room at the Arizona Biltmore. Speaking from her experience as a clinician, Dr. Shunney, along with a variety of panelists, will be covering various discussion topics around the CBD conversation: from sourcing to quality control to clinical applications. Attendees are encouraged to come early as seating is limited.

For more information or to schedule a meeting with the Company management, please contact Robert Haag at cvsi@irthcommunications.com.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division in manufacturing, marketing and selling plant–based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.

FORWARD–LOOKING DISCLAIMER

This press release may contain certain forward–looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward–looking in nature and subject to risks and uncertainties. Such forward–looking statements by definition involve risks, uncertainties.

Medovex Corporation Schedules First Human Case for DenerveX(TM) System

ATLANTA, GA—(Marketwired – Jun 27, 2017) – Medovex Corp. (NASDAQ: MDVX) (“Medovex” or the “Company”), a developer of medical technology products, today announced that it has scheduled its first human cases for its DenerveX™ System in the EU to commence during mid–July, followed by other cases throughout the balance of the month and in August. Dr. Martin Deeg, an Orthopedic Surgeon from Stuttgart, Germany will be the first surgeon to utilize the new device.

The Company previously announced that it had received its first three commercial orders for its DenerveX System on the heels of receiving CE Mark approval for the system allowing it to be marketed in Europe. The first commercial orders of the DenerveX System included both the DenerveX Kit containing the DenerveX Device and the DenerveX Pro–40 Generators for Germany, UK and Italy.

Manny Sablowski, Sr. Vice President of Sales and Marketing, stated, “We are pleased to be building atop recent momentum having established near term dates for the first human cases in the EU. The first human cases follow the recent receipt of stocking orders from our distributors EDGE Medical of Manchester England, TCB Ortho Division of Germany, and AlfaMed of Porto San Giorgio, Italy.”

Sablowski continued, “In recent weeks, we also received additional positive feedback holding a successful DenerveX training session with our Italian distributor. I have high hopes that all our other distributors are equally excited like the AlfaMed team. Their twelve sales representatives are all specialists in the Spinal field and clearly understand Facet Joint Syndrome.”

Facet Joint Syndrome (FJS), also known as spinal osteoarthritis, spinal arthritis, or facet joint osteoarthritis, is a significant health and economic problem affecting millions each year in the United States, the EU, and rest of the world. Current treatment options are generally temporary and there is no proven long–lasting option for FJS.

The DenerveX System is differentiated from radiofrequency ablation technologies by denervating and removing capsular tissue from the Facet Joint in one single procedure. Treatment results from the combined effect of a deburring or polishing action and RF ablation treatment on the Facet Joint. Using this new technique, the slowly rotating burr removes the targeted facet joint synovial membrane and joint surface while the heat ablation destroys tissue and denudes any residual nervous and synovial membrane overlying the joint, removing the end point sensory tissue of the joint.

Published studies indicate that lower back pain is the fifth most common reason for U.S. doctor office visits, the most common cause for activity limitations in persons under the age of 45, and a driver of physician opioid prescribing patterns. Additionally, research indicates that total health care expenditure for LBP in the U.S. exceeds $100 billion dollars annually. The DenerveX System was specifically designed to address long term lower back pain management seeking to alleviate, and/or mitigate pain, in addition to potentially reducing dependence on pharmaceutical based remedies.

The DenerveX System consists of the DenerveX Device Kit, containing a single use medical device and the DenerveX Pro–40 Power Generator. The DenerveX system is not yet FDA cleared.

About Medovex

Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. To learn more about Medovex Corp., visit www.medovex.com

Safe Harbor Statement

Certain statements in this press release constitute “forward–looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward–looking statements. While the Company believes these forward–looking statements are reasonable, undue reliance should not be placed on any such forward–looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the “SEC”), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

CoverHound and eHealth Partnership Expands Insurance Ecosystem for Consumers and Small Business Owners

SAN FRANCISCO, CA—(Marketwired – June 27, 2017) – Online property and casualty insurance comparison platform CoverHound announced today a partnership with eHealth (NASDAQ: EHTH). eHealth, a leading private online health exchange serves small businesses looking to compare and purchase health insurance from top insurers and enroll in coverage online.

Through this partnership, both companies will expand their insurance offerings and services to businesses. eHealth will offer their growing small business (SMB) customer base a compelling way to compare and purchase different types of business insurance by leveraging the digital insurance marketplace and call center agency operations that CoverHound offers.

By partnering with eHealth, CoverHound gives SMB customers access to eHealth's online health insurance marketplace and call center. Customers can search through different health insurance plans from the nation's leading providers at eHealth.com.

“Today, in many states eHealth helps customers compare health insurance plans from as many as eight different health insurance companies in their area,” said Seth Teich, eHealth's Senior Vice President, Business & Corporate Development. “CoverHound shares one of our core values, which is to give people as much information as possible to help them make informed choices when they buy insurance. We're thrilled to be partnering with CoverHound so that we can increase the types of insurance benefits we can offer our small business customers.”

“eHealth extends our network in a way that's consistent with our commitment to the needs of the mobile and digital consumer,” says Keith Moore, CEO of CoverHound. “Customers want and expect a marketplace that gives them a streamlined insurance shopping experience across multiple insurance options and that is our mission.”

About CoverHound

CoverHound is an insuretech company for consumers and businesses to easily compare and purchase insurance, built to deliver fast, accurate and actionable rates from leading US carriers based on their specific needs. Some of the top carriers include Chubb, Liberty Mutual, Hiscox, Progressive, Berkshire Hathaway Direct, Safeco, The General, Mercury, Hartford Steam Boiler and others to offer the most competitive rates in 50 states. Developed by a team with deep insurance and online financial services experience, CoverHound is dedicated to providing the best in class customer experience.

About eHealth

eHealth, Inc. (NASDAQ: EHTH) owns eHealth.com, a leading private online health insurance exchange where individuals, families and small businesses can compare health insurance products from leading insurers side by side and purchase and enroll in coverage online. eHealth offers thousands of individual, family and small business health plans underwritten by many of the nation's leading health insurance companies. eHealth (through its subsidiaries) is licensed to sell health insurance in all 50 states and the District of Columbia. eHealth also offers educational resources and powerful online and pharmacy–based tools to help Medicare beneficiaries navigate Medicare health insurance options, choose the right plan and enroll in select plans online through Medicare.com (www.Medicare.com), eHealthMedicare.com (www.eHealthMedicare.com) and PlanPrescriber.com (www.PlanPrescriber.com).